NCT01060904 2014-12-18A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin LymphomaSeagen Inc.Phase 1 Completed51 enrolled
NCT01872923 2014-06-16Dose Escalating Study for Amphinex-based PCI of Bleomycin.PCI Biotech ASPhase 1 Completed3 enrolled
NCT00027521 2012-09-19Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic CancerIchor Medical Systems IncorporatedPhase 1 Withdrawn